Allinky Biopharma

Allinky.png

Contact information

Allinky Biopharma
Miguel Vega
C/Faraday 7. Campus de Cantoblanco
Madrid
Madrid
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Drug development
      • Drug discovery
    • Therapeutic areas
      • Analgesia & Pain
      • Inflammatory diseases
      • Oncology
      • Central nervous system
      • Metabolic disorders / Endocrinology

Allinky Biopharma is focused on the discovery and development of small molecule drugs for the treatment of chronic inflammatory conditions, age-related degenerative diseases and cancer.

Products and services

Scientific and clinical research have shown that sustained oxidative stress, chronic inflammatory condition and progression cell missignalling are key factors in diseases such as Alzheimer's, ictus, rheumatoid arthritis, osteoarthritis, diabetes type II, atherosclerosis and certain types of cancer. Allinky develops novel therapeutics capable of modulating abnormal cell-molecular signals behind these diseases and thus contributing to restore normal cell-gene expression. Therefore, Allinky seeks to become a well-known player in the application of molecular-based medicine to fight prevalent diseases.